Selected References:
- Cheema R, et al. 2023. Protecting Breastfeeding during the COVID-19 Pandemic. Am J Perinatol. 40(3):260-266.
- Dernoncourt A, et al. 2023. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase®). BioDrugs.37(1):73-87.
- Food and Drug Administration. 2025. Kevzara® (sarilumab) Prescribing Information. Available at: https://www.accessdata.fda.gov>label.
- Khiali S, et al. 2021. A comprehensive review on sarilumab in COVID-19. Expert Opinion on Biological Therapy; 21(5):615-626.
- Krysko KM, et al. 2023. Family planning considerations in people with multiple sclerosis. Lancet Neurol. 22 (4):350-366.
- Garcia-Vicuña R, et al. 2020. Subcutaneous Sarilumab in hospitalized patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomized controlled trial. Trials; 21(1):772.
- McCarty D, Robinson A. 2018. Efficacy and safety of sarilumab in patients with active rheumatoid arthritis. Ther Adv Musculoskelet Dis; 10(3):61-67.
- Mizutani Set al. 2023. A Woman with Rheumatoid Arthritis Who Successfully Delivered a Healthy Child with Continuous Administration of Sarilumab Throughout Pregnancy. Intern Med.62(4):633-636.
- Nana M, et al. 2024. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study. Lancet Rheumatol. 6(9):e625-e635.
- Prieto-Peña D, et al. 2021. Biologic agents and small-molecule inhibitors in systemic autoimmune conditions: an update. Pol Arch Intern Med; 131(2):171-181.
- Raimondo et al. 2017. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis. Drugs Des Devel Ther. 11:1593-1603.
- Rüegg L, et al. 2025. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis.84(6):910-926.
- Saito J, et al. 2023 Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi-institutional study. Br J Clin Pharmacol.
